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FROM THE DIRECTOR 
2015 was a year of major change and progress for HIV prevention 
in the United States. 
CDC released an analysis showing that HIV diagnoses fell by 19 percent over the past
decade, driven by dramatic declines among heterosexuals, people who inject drugs,
and African American women and heterosexual men. CDC also reported that, thanks
to sustained testing efforts, the proportion of Americans with HIV who know their 
status has reached an all-time high of 87 percent. Meanwhile, implementation of the 
Affordable Care Act continued to increase access to critical HIV testing, prevention, 
and care services nationwide.
While this progress is encouraging, we now 
have the potential to go much further. 
Recent scientific advances have given us 
powerful new strategies to stop HIV, including 
improved testing techniques, early treatment 
with antiretroviral medications, and 
pre-exposure prophylaxis (PrEP). 
But these advances aren’t yet reaching many people 
in need. Surveillance data show just 57 percent of 
people diagnosed with HIV are receiving care for 
their infection, and only 55 percent have their virus 
suppressed through treatment. PrEP is reaching only 
a small fraction of those who could benefit from it, in 
part because many health care providers are unaware 
of its promise. There are substantial gaps between 
Southern states and the rest of the country on critical 
measures including death rates among people with 
diagnosed HIV and knowledge of HIV-positive status. 
As a result, our nation’s progress has been uneven. 
For example, HIV diagnoses dropped 18 percent 
among white men who have sex with men (MSM) 
between 2005 and 2014, but increased 24 percent 
among Latino MSM – a strong signal that we must do 
more to reach Latino MSM with effective prevention. 
Diagnoses increased 22 percent among black MSM, 
although the increases have leveled off since 2010, 
signaling that intensified prevention programs for 
black gay and bisexual men are beginning to pay off. 
In the face of these challenges, our task 
is clear: to put HIV prevention advances 
to work for everyone in need. 
Everyone – regardless of who they are or where 
they live – should have the opportunity to protect 
themselves and their partners from HIV. 
At CDC’s Division of HIV/AIDS Prevention, our 
efforts are guided by the National HIV/AIDS Strategy: 
Updated to 2020. The Strategy includes ambitious 
targets for HIV prevention, treatment, and care 
(see sidebar). 
In 2015, CDC made major new investments to 
help deliver high-impact prevention at the state 
and local levels, particularly through demonstration 
projects for gay and bisexual men of color. We 
worked to increase PrEP awareness and encourage 
its adoption by health care providers and people 
at risk. We utilized cutting-edge surveillance tools 
to support prevention programs and respond to 
outbreaks. We worked to address key data gaps, 
including the urgent need for better data on HIV 
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But CDC’s efforts are only part of the equation. Successfully
meeting the goals of NHAS will depend on the efforts of many
stakeholders, including state and local health departments,
community-based organizations (CBOs), health care providers,
and policymakers inside and outside government. In particular,
it will be critical for all states to take action to improve their HIV
care and prevention outcomes. 
Our ability to accelerate progress and meet national goals will
depend on our collective willingness to think in new ways; to
focus on what works; to confront ongoing social, economic, and
structural barriers to prevention; and to prepare for tomorrow’s
advances by capitalizing on the tools we have today. 
Success is within our grasp. 
But we will need to do all we can to sustain momentum. We
must keep driving down HIV infections, especially among gay
and bisexual men and African American women. We must
reach Latinos, especially Latino MSM, with culturally relevant
prevention, including access to PrEP and other tools. We must
address emerging issues like increasing injection drug use in
both rural and urban communities nationwide. We must better
meet the needs of transgender people. We must do more to
link individuals to care and treatment the same day they receive
their HIV test results. And we must do a better job of ensuring
that everyone living with HIV has unfettered access to
quality health care. 
It is an ambitious vision, but it can be our reality tomorrow –
if we all commit to it today. I’m confident that, together,
we will make bold new progress against HIV and put a stop
to new infections in the United States.
Sincerely, 
Eugene McCray, MD 




UPDATED TO 2020 
In July 2015, the 
National HIV/AIDS 
Strategy (NHAS) was 
updated to reflect the 
current state of HIV in 
the United States and 
provide bold new goals 
for the next five years. 
The updated strategy 
to 2020 includes 10 key 
indicators that federal 
agencies and their state 
and local partners must 
work to address for 
example, increasing the 
percentage of people 
living with HIV who know 
their serostatus to at least 
90 percent, and increasing 
the percentage of people 
with diagnosed HIV infection 
who are virally suppressed 
to at least 80 percent. Over 
time, additional indicators 
will be added to track 
progress in increasing 
PrEP access, reducing 
the epidemic among 
transgender persons, 




           
            
              
              
                 
 
              
                 
                 
                   
             
          
                     
                       
                   
                        
             
           
                 
              
                
             
         
                
                 
                
                  
               
          
               
               
                
                   
             
         
 
→ HIGH-IMPACT HIV PREVENTION STRATEGIES
�
CDC’s High-Impact Prevention approach involves using 
combinations of scientifically proven, cost-effective, and 
scalable interventions, with particular attention to the 
most heavily affected populations and geographic areas. 







HIV TESTING AND DIAGNOSIS. Testing is the gateway to 
HIV prevention and care. CDC funds testing services and 
is working with partners to implement routine and regular 
testing for higher-risk groups, and to speed the adoption of 
new testing technologies that enable earlier, faster diagnosis. 
HIV CARE AND TREATMENT. Early antiretroviral treatment 
not only improves the health of people living with HIV, but 
also makes them far less likely to transmit the virus. A top 
priority for CDC is ensuring that people diagnosed with HIV 
are linked to – and retained in – HIV care and treatment, 
so they can achieve and maintain viral suppression. 
ACCESS TO CONDOMS. Consistent, correct condom 
use continues to be an essential prevention strategy. All 
CDC-funded health departments and CBOs are required 
to provide condom distribution services for people living 
with HIV and for people at high risk. 
PrEP AVAILABILITY AND UPTAKE. HIV-negative people 
who take pre-exposure prophylaxis (PrEP), a daily anti-HIV 
pill, as directed can dramatically reduce their risk of 
becoming infected. CDC is working to build awareness 
of PrEP among providers and potential clients and ensure 
it is offered to all those who are eligible. 
RISK REDUCTION AND SUPPORT. A number of behavior-
change interventions have been proven effective for HIV 
prevention, although not all are cost-effective and scalable. 
CDC has prioritized support for interventions that help 
people living with HIV remain in care and avoid transmission 
to others. CDC-funded partners may also pursue cost-
effective behavioral interventions targeting HIV-negative, 
high-risk individuals. 
8
A Snapshot of HIV Infections in the United States
In the United States today, approximately 1.2 million people are living with HIV. About 87 
percent of them are aware that they are infected – substantially higher than a decade ago.
Successful HIV prevention and treatment efforts have helped to dramatically reduce HIV-related illness 
and deaths, slow HIV transmission rates, and decrease the annual number of new HIV diagnoses. Yet 
despite these successes, there is still an urgent need for HIV prevention. Many people living with or at 
risk for HIV are not receiving necessary prevention or care, and with more people living with HIV than 
ever before, there are more opportunities for HIV transmission.








CDC data show that the 
number of HIV diagnoses  
has declined significantly 
in the last decade, driven by 
declines among heterosexuals, 
people who inject drugs, 
African American women  
and heterosexual men –  
with especially steep declines 
among black women.
Among MSM, diagnoses 
increased six percent overall 
in the last decade, driven by 
increases among black and 
Latino MSM. Diagnoses have 
recently leveled off among 
black MSM, who remain most 
affected by HIV, but have 





































       
 
     
   
 
Transgender persons, especially
transgender women of color, can be
at particularly high risk for HIV.
However, reliable data on this
population remain limited. According
to a 2008 meta-analysis of available,
relevant, and reliable data, investigators
estimated that approximately 28 percent
of transgender women in the U.S.
were living with HIV. For transgender
women of color, the picture is more
stark. The same study estimated
that approximately 56 percent of
African American transgender
women were living with HIV.1 
Many Americans living with HIV are not
receiving the treatment and care they
need to improve their health and prevent
transmission to others. 
CDC surveillance data show just 57
percent of people diagnosed with HIV
are receiving care for their infection,
and only 55 percent have their virus
suppressed through treatment.
Southern states bear the greatest burden
of HIV infection, illness, and deaths
among people with HIV, reflecting
major gaps in access to high-quality
prevention and care. 
1ST QUARTILE (7.9-15.5) 
2ND QUARTILE (15.6-19.0) 
3RD QUARTILE (19.1-21.3) 
4TH QUARTILE (21.4-30.8) 
Fig 3: Estimated Percentage of Transgender Women Living
with HIV Infection1 
1 Herbst JH, Jacobs ED, Finlayson TJ, McKleroy VS, Neumann MS, Crepaz N. Estimating
HIV prevalence and risk behaviors of transgender persons in the United States: a
systematic review. AIDS Behav. 2008 Jan;12(1):1-17. Epub 2007 Aug 13. 
Fig 4: Retention in HIV Medical Care and Viral Suppression 
among Persons Aged ≥13 Years Living with
Diagnosed HIV Infection, by Sex, 2013 –
32 States and the District of Columbia 
RETAINED IN NOTE:  Data include persons with a diagnosis of HIV 
infection regardless of stage of disease at diagnosis. 
Retained in medical care was defined as ≥2 tests (CD4 or 
VL) ≥3 months apart in 2013. Viral suppression was defined 




Fig 5: Death Rate Among People with Diagnosed HIV,



























































Innovative Funding to Deliver HIV Prevention Advances
�
CDC Renews Awards to
Community-Based Organizations 
CBOs have long been critical partners in 
HIV prevention. While relatively small in 
comparison to CDC’s health department 
commitments, direct funding to CBOs is an 
important component of DHAP’s prevention 
portfolio. In July 2015, the Division awarded 
$43.2 million per year over five years to 90 
CBOs and their clinical partners nationwide 
to deliver HIV prevention services to those at 
greatest risk, including people of color, MSM, 
transgender individuals, and people who 
inject drugs. 
The awards reflect CDC’s increased focus on 
delivering the latest high-impact prevention 
tools in combination. Most significantly, CBOs 
are now required to prioritize diagnosing 
infection among people living with HIV, linking 
them with care and treatment, and providing 
the support they need to stay in care. CBOs are 
also funded to help ensure that HIV-negative 
individuals at high risk have access to proven 
prevention tools including PrEP. 
Each of the funded organizations has 
demonstrated experience and expertise working 
with the populations most affected by HIV. 
Of the 90 CBOs, 67 primarily serve African 
Americans and 15 primarily serve Hispanics; 64 
primarily serve MSM. CDC provided extensive 
technical assistance to help CBOs apply for the 
funding and offers ongoing support to help 
ensure their success. 
New Awards for Health Department
Demonstration Projects Help Deliver
Prevention Advances to Gay and Bisexual
Men and Transgender People 
In March 2015, DHAP announced plans to
intensify prevention efforts for gay and bisexual
men and transgender people, particularly people
of color. In 2015, CDC directed over $37 million
to help state and local health departments fund
demonstration projects to increase access to
two powerful, but underutilized, HIV prevention
tools: PrEP and Data to Care. The funding will
drive wider adoption of these tools where they are
urgently needed and provide lessons on how to
expand their use nationwide.
→
→
PrEP: CDC estimates that 1 in 4 sexually active
gay and bisexual men are at substantial risk
for HIV and might benefit from PrEP (see page
24 for details). The new funding is helping 12
health departments ensure gay and bisexual
men and transgender people are aware of PrEP
and can find an appropriate PrEP provider in
their community. Funded health departments
will also ensure that more health care
providers are informed about PrEP and know
when and how to offer it. 
DATA TO CARE: The new funding is also helping
5 health departments implement Data to Care,
a CDC-developed approach that uses routinely
collected HIV surveillance data to identify and
follow up with people with diagnosed HIV who
are not receiving care. Currently, only about
57 percent of gay and bisexual men diagnosed








       
       
   
       
       
     
       
         





       
         
           
         
         
       
       
       
     
     
         
       
       
         
     







is a community-based 
organization that addresses 
social and health disparities 
that affect black MSM, 
transgender individuals, 
and their families in 
Dallas County, Texas. The 
organization engages these 
communities in many ways, 
including the use of social 
media platforms such as 
Facebook, Twitter, Instagram, 
and mobile dating apps. 
With CDC’s support, 
Abounding Prosperity is 
working to expand access 
to HIV testing and improve 
linkage to care for people who 
test positive. In 2015, more 
than 50 percent of people 
who received HIV testing 
through its programs tested 
positive, indicating that these 
programs were successfully 
reaching communities with 
some of the highest rates 
of undiagnosed HIV and 
helping them obtain needed 
care and prevention. In fact, 
Abounding Prosperity also 
exceeded its goal for linking 
newly diagnosed HIV-positive 












   
   
 












CDC Supports Comprehensive HIV
Prevention Projects for Gay and Bisexual
Men of Color 
CDC also announced in March that it will lead a
multi-agency initiative to launch demonstration
projects that address the HIV prevention and
care needs of gay and bisexual men of color. The
initiative is designed to address many of the
critical social determinants that influence health
in these populations. 
Up to $60.5 million will be awarded over 4 years
to help state and local health departments
collaborate with local CBOs, clinics, and other




Deliver comprehensive HIV prevention services
to those at high risk 
Provide linkage to a wide range of critical
services such as substance abuse treatment,
mental health care, housing, and job training 
Improve workforce capacity and cultural
competency so that prevention efforts are
tailored to the unique needs of gay and bisexual
men of color 
This effort is supported by the Department of
Health and Human Services Secretary’s Minority
AIDS Initiative Fund (SMAIF), which advances




Technical Assistance and Prevention Policy Guidance
�
New Toolkit Helps People with HIV Take
“Every Dose, Every Day” 
To ensure more people living with HIV achieve 
viral suppression, CDC has developed new 
interventions to improve linkage to medical 
care, retention in care, and adherence to 
medication regimens. 
In September 2015, CDC launched the Every 
Dose, Every Day™ toolkit, a suite of medication 
adherence resources for health care providers 
and people living with HIV. The toolkit features 
flexible, evidence-based interventions to 
help health care providers assess and manage 
medication adherence, and work with patients 
to overcome any barriers. It also includes a free, 
easy-to-use mobile app designed to help people 
living with HIV keep track of medications, 
appointments, and lab results. The app is 
available for download from iTunes and 
Google Play. 
The toolkit is one of many effective prevention 
approaches included in CDC’s online 
compendium at https://effectiveinterventions. 
cdc.gov/. The site houses information on 
accessible, evidence-based HIV prevention 
programs to promote healthy behaviors among 
people at risk for transmitting or acquiring HIV, 



































CDC Strengthens States’ Outbreak
Response and Preparation 
For much of 2015, CDC supported the state
of Indiana’s response to an outbreak of HIV
infections among people who inject drugs
(PWID) in rural Scott County. The outbreak was
a powerful reminder of the ever-present risk of
a resurgence of HIV among PWID in the United
States, particularly given evidence of increasing
injection drug use in areas that have had
relatively few HIV cases in the past. 
At the request of Indiana health officials,
CDC provided technical assistance and
dispatched a team of disease intervention
specialists and epidemiologists to augment
the state’s public health staff on the ground.
Specifically, CDC personnel helped to reach
affected individuals with HIV and viral hepatitis
testing and linked those who tested positive to
medical care. CDC also supported intensive work
to identify and follow up with sexual and
needle-sharing partners of those who had
been diagnosed with HIV. 
Since the factors driving the outbreak were
not unique to Scott County, CDC also issued
a Health Advisory in April 2015 to alert public
health departments and providers nationwide
of the increase in hepatitis C infections and the
possibility of current or future HIV outbreaks
among PWID. The advisory provided guidance on
how to identify and prevent such outbreaks. CDC
continues to provide states with information that
can help them identify potential outbreaks and
respond to them early. 
Understanding State & Local Responses
to HIV Policy Changes 
Since 2010, CDC’s health department and CBO 
partners have encountered major changes in 
national health care policy, from the National 
HIV/AIDS Strategy to the Affordable Care Act. 
In 2015, DHAP conducted in-depth interviews 
and consultations with 27 partners in 21 
jurisdictions (19 from health departments and 
eight from CBOs), to understand how they have 
adapted. The results will help DHAP make 
well-informed decisions on how best to monitor 
HIV infections and the impact of prevention 
programs, improve partners’ capacities, and 
support effective public health policies. 
The discussions indicated that partners are 
not only adapting, but are strengthening their 
programs in response to policy changes. Health 
departments, in particular, reported significant 
advances in program integration and service 
delivery, and said they are increasingly focusing 
their activities and local funding allocations on 
the most urgent needs. CBO representatives 
reported that their work has been complicated 
by the need to integrate new policies, and 
acknowledged that strong collaborations 
with federal, health department, and clinical 
partners are now critical to their success. Since 
last year, CDC has placed greater emphasis 
on including such formal collaborations in its 
direct funding agreements with CBOs, and has 
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→   CDC’S ONGOING PARTNERSHIPS WITH
STATE AND LOCAL HEALTH DEPARTMENTS 
CDC’s largest investment in  HIV prevention, by far, continues to be  
its  funding for state, territorial,  and local  health  departments. 
The  launch of  the  current  funding cycle  (2012-2016)  was a  
major step toward the implementation of CDC’s  High-Impact  
Prevention  approach. To  ensure prevention resources are  
focused  where  they are  needed  most,  funds  are  allocated   
based  on  the  number  of  people  diagnosed  with  HIV  in  each   
state, territory,  or  city.  While  health  departments  use  funds  
differently based  on local  epidemiology  and  needs,  priority   
is given to  CDC’s  priority strategies  outlined on  page 7. 
With  CDC’s  support, for example,  the  New York City 
Department of Health and Mental Hygiene  continues to  
enhance  its  portfolio  of  high-impact  prevention  programs  with  
innovative  approaches  that target  HIV-negative  people  at  high  
risk and  HIV-positive people who are not  engaged in care.  
Using an  “HIV  neutral continuum of care”  model  –  meaning  
that  both  positive and  negative HIV tests  should prompt  
linkages to prevention  – the  department is  increasing access to  
pre- and  post-exposure  prophylaxis,  syringe  service  programs,  
HIV  medical care,  and  patient  navigators  who  help  people  
access  essential  support  services.  The  Department  also  plays  
a vital role in New York State’s  “Ending  the  Epidemic”  initiative,  
which is expanding  HIV prevention  activities  with  the  goal of  




Over the past 20 years, 
Positive Impact Health 
Centers has been a leading 
provider of HIV testing 
and prevention services in 
Atlanta, Georgia, working 
with one of the most-
affected populations in the 
metro area young African 
American MSM. With CDC’s 
support, Positive Impact’s HIV 
testing program identified 44 
people with newly diagnosed 
HIV infections from July 
through December 2015 and 
successfully linked more 
than 90 percent of these 
individuals to medical care. 
Of the HIV tests funded 
directly by CDC, 75 percent 
were walk-ins (based on 
word-of-mouth referrals), 
while the remaining tests 
were conducted through field 
outreach. Positive Impact 
attributes its success not 
only to its reputation in the 
community and partnerships 
developed over the past 
20 years, but also to its 
culturally sensitive, non-
judgmental approach toward 
































































CDC Analysis of HIV Diagnoses Shows Encouraging,
but Uneven, Progress 
In a plenary address at the National HIV Prevention Conference in December
(see page 23), Dr. Eugene McCray announced the results of a DHAP analysis of
short- and long-term HIV diagnosis trends in the United States.
Overall, the analysis suggests that national HIV prevention efforts are having a substantial impact, although
progress is uneven. From 2005 to 2014, annual HIV diagnoses fell 19 percent, driven by dramatic declines
among heterosexuals, people who inject drugs, and African American women and heterosexual men – with
the steepest declines among black women. However, the same level of success was not seen among all gay
and bisexual men, signaling urgent needs for intensified prevention among young, African American and
Latino MSM in communities nationwide. 
State and National Reports Reveal
Progress, Challenges, and Disparities 
In December 2015, DHAP released a pair of
reports that provide new insights on national and
state-level progress against HIV. Both reports
track important indicators that align with the
original National HIV/AIDS Strategy (through
2015) and with DHAP’s 2011-2015 Strategic Plan. 
The National HIV Prevention Progress Report
describes progress toward 15 critical indicators.
Results show that annual targets were met for
nine of 15 indicators, including increasing the
overall percentage of people living with HIV
who are diagnosed, linked to medical care, and
virally suppressed. However, targets were not
yet met for other indicators, such as increasing
viral suppression among Hispanics/Latinos with
diagnosed HIV.
CDC’s State HIV Prevention Progress Report provides
insights on regional disparities that play a role
in driving HIV infections in the nation. It reveals
striking gaps between southern states and the
rest of the country on two key indicators –
death rates among people with diagnosed HIV,
and knowledge of HIV-positive status. Since
fewer people living with HIV in the South are
aware of their infection than in any other region,
fewer people in the South who are living with
HIV receive timely medical care or treatment,
fewer have their virus suppressed, and a
disproportionate number are missing out on the
opportunity to preserve their health and avoid
transmitting HIV. Mortality remains alarmingly
high as a result – people living with HIV in some
southern states have death rates that are three
times higher than people living with HIV in some
other states.
Even with recent increases in federal funding for
HIV prevention in the South, success ultimately
depends on a variety of prevention partners,
including policymakers, at the state, county, and
municipal levels. CDC called on states to consider
aggressive steps to improve prevention and care
outcomes and make more rapid progress toward
goals established by the National HIV/AIDS
Strategy. These steps were described in a new

































Study Reinforces Prevention Benefits of
Improved Testing, Treatment, and Care 
In February 2015, DHAP researchers published 
a study in JAMA Internal Medicine showing that 
nine in 10 new HIV infections in the United 
States could be averted by diagnosing people 
living with HIV and ensuring they receive 
prompt, ongoing care and treatment. 
Researchers estimated that 91.5 percent of 
new HIV infections in 2009 were attributable 
to HIV-positive persons who were not in 
medical care, including those who didn’t know 
they were infected. By comparison, less than 
six percent of new infections could be attributed 
to persons with HIV who were in care and 
receiving antiretroviral therapy. The study 
provides a strong case for investing in efforts 
to diagnose people living with HIV, engage 
them in ongoing care, and help them adhere 
to medication regimens. 
Many States Positioned to Meet National
HIV Testing Goal, Analysis Finds 
Thanks to expanded testing efforts, most
Americans living with HIV are aware of their
infection. CDC estimates that the proportion of
HIV-positive people who have been diagnosed
increased from 81 percent in 2006 to 87 percent
in 2012. If this progress continues, the nation will
soon reach a key target of the National HIV/AIDS
Strategy: increasing the percentage of people
living with HIV who know their serostatus to at
least 90 percent. 
To help monitor progress towards this target,
DHAP researchers used surveillance data to
estimate the prevalence of diagnosed and
undiagnosed HIV in each state. Their analysis
showed uneven progress: the proportion of
people with HIV who were diagnosed ranged from
77 percent in Louisiana to 90 percent or more in
Colorado, Connecticut, Delaware, Hawaii, and
New York.
To ensure more states reach the 90 percent
target, the study authors recommended increased
efforts to implement routine HIV screening in
health care settings and targeted testing in non-
health care settings in hard-hit communities. 
Study Shows Death Rate Down Among
African Americans with HIV 
On National Black HIV/AIDS Awareness Day 
(February 7), CDC researchers published a study 
showing important signs of progress in the fight 
against HIV among African Americans. The 
analysis, based on data from CDC’s National HIV 
Surveillance System, showed that from 2008 to 
2012, the death rate declined 22 percent among 
all HIV-positive Americans, and fell by even more 
– 28 percent – among those who were African 
American. Despite this progress, however, racial 
disparities persist: the death rate for African 
Americans living with HIV in 2012 was 13 percent 
higher than the rate for whites and 47 percent 
higher than the rate for Hispanics. The study 
authors emphasized that despite progress on 
death rates and in other areas, HIV continues 
to have a disproportionate impact in many 
African American communities, and requires 
sustained commitment to using the best available 
























































DHAP Hosts Signature U.S. Conference on HIV Prevention 
In December, DHAP welcomed more than 3,000 researchers, public health
professionals, community leaders, and advocates to the 2015 National HIV Prevention
Conference in Atlanta. The meeting, organized by CDC in partnership with 29 federal,
state, and community organizations, is the only conference dedicated solely to HIV
prevention efforts in the United States. In fact, the 2015 conference was the first
major gathering of the nation’s HIV prevention community since landmark scientific
advances altered the prevention landscape early in the decade. It was a critical
opportunity for the field to share lessons on the effective implementation of today’s
HIV prevention tools. 
Results from more than 750 scientific studies





A 20-city study finding that PWID who live in
cities with syringe service programs (SSPs) are less
likely to report high-risk injection behaviors (e.g.,
injecting with used syringes) than those who live in
cities with no large-scale SSPs. The study provides
important real-world evidence of the prevention
benefits of SSPs, which, for the first time in many
years, can now be supported with CDC and other
federal funds. 
An analysis that used HIV nucleotide sequence data
collected through molecular surveillance to identify
transmission networks and predict the growth of
HIV transmission clusters. These types of analyses
may offer an effective way to help target HIV
prevention resources and interrupt transmission.
Research that examined HIV testing and linkage
to care among transgender people at CDC-funded
HIV testing sites, revealing important differences
in demographic characteristics, risk behaviors, and
HIV status between transgender subgroups, which
may help strengthen prevention strategies. 
MORE THAN 750 SCIENTIFIC STUDIES WERE
PRESENTED AT THE 2015 NATIONAL HIV

































PrEP Implementation Gets Smarter with
New CDC Research 
While PrEP has generated great interest and
enthusiasm in the HIV prevention community,
there are many unanswered questions about how
to deliver PrEP to everyone who can benefit. In
2015, DHAP researchers delivered insights to the
field on a range of critical PrEP implementation
issues. For example: 
→
→
CDC’s December 2015 “Vital Signs” reported
that PrEP has the potential to benefit many
Americans who are at risk for HIV, and that
PrEP scale-up efforts should be accelerated.
The report estimated that 25 percent of sexually
active gay and bisexual men, nearly 20 percent
of adults who inject drugs, and less than one
percent of heterosexually active adults are at
substantial risk for HIV infection and should be
counseled about PrEP. DHAP continues to make
PrEP a central focus of its prevention programs
for these populations. 
At the National HIV Prevention Conference,
DHAP researchers revealed data showing a
substantial increase in awareness of PrEP and
willingness to either use or prescribe it. For
example, an online survey of more than 3,000
gay and bisexual men found that 71 percent were
aware of PrEP, although only seven percent had
ever used it. Another study, based on a national
survey of primary care clinicians, found that
awareness of PrEP increased from 24 percent in
2009 to 64 percent in 2015, and that clinicians
were more likely to prescribe PrEP once they
received accurate information about it. 
CDC’S DECEMBER 2015  
“VITAL SIGNS” ESTIMATED 
THAT 25 PERCENT OF 
SEXUALLY ACTIVE GAY AND 
BISEXUAL MEN, NEARLY  
20 PERCENT OF ADULTS 
WHO INJECT DRUGS, AND 
LESS THAN ONE PERCENT 
OF HETEROSEXUALLY 
ACTIVE ADULTS ARE AT 
SUBSTANTIAL RISK FOR HIV 
INFECTION AND SHOULD BE 






























Keeping Pace with New HIV
Tests through Project DETECT
Three decades after the first HIV
tests came onto the scene, testing
technologies continue to evolve
quickly. These advances bring new
opportunities to diagnose HIV
early in the course of infection,
but also raise new questions about
which technologies to use, for
whom, and when.
DHAP’s Project DETECT
(Diagnostic Evaluation To Expand
Critical Testing Technologies)
kicked off in 2015 to provide
answers. Through DETECT,
researchers are assessing
differences in the ability of new
tests to diagnose HIV infection
in its earliest, “acute” stage. The
project, which is being conducted
through a grant to the University
of Washington, will help CDC
update HIV testing guidance for
physicians and other HIV test
providers. It is also expected
to provide new insights on the
characteristics of acute HIV





















New Online Tool Helps Users Weigh HIV Risks and
Prevention Options 
As prevention science evolves and new options such as PrEP become available, it is
important to help people choose the best strategies to protect themselves and their
partners from HIV. 
At the National HIV Prevention Conference, DHAP launched the beta version of an online HIV Risk
Reduction Tool (www.cdc.gov/hivrisk), which can help individuals understand and reduce their risk of
acquiring or transmitting HIV. The tool includes an interactive personal risk estimator, allowing users to
compare the risk of different sexual activities and to see how various prevention methods and risk factors –
alone or in combination – could change their level of protection or risk. DHAP plans to update and refine the












































































































                     
                     
 
         
                   
           
 
           
                        
                    
 




National Hispanic Medical Association  holds  panel  discussion  and  
national  Twitter  chat  for  National  Latino  Aids  Awareness  Day  (NLAAD),  
including  White  House  speakers;  promotes  Act Against AIDS  materials   
to  55,000  Hispanic  healthcare  providers 
ONLINE 
OCTOBER 
ASPIRA Association,  an  organization focused  on developing  the  





National Black Justice Coalition  (NBJC)  provides  Act Against AIDS 
materials and educational sessions at its  summit of students and 
administrators  from  13  Historically Black  Colleges  and  Universities 
WASHINGTON, DC 
NOVEMBER 
National Medical Association  disseminates  Act Against AIDS  campaign 




AIDS United partners with Campus Pride to develop a series of World 
AIDS Day (Dec. 1) blog posts at universities throughout the United States 
TUSKEGEE, ALABAMA 
DECEMBER 
Southern Christian Leadership Foundation (SCLF) hosts a county-wide 
World AIDS Day Health Fair, featuring Act Against AIDS materials and HIV 
testing through partnerships with local health departments 
DALLAS, TEXAS
DECEMBER 
Dallas Rainbow Council of the League of United Latin American Citizens 
(LULAC) joins with several partners to host a World AIDS Day Event 




NBJC  World  AIDS  Day  blog  post is  featured  on  the  front  page  of  
Huffington  Post Black  Voices 
29 
   
 MOLECULAR SURVEILLANCE 
Molecular Surveillance: 
A Powerful Tool for Understanding 
HIV Transmission 
DHAP is using cutting-edge technologies like molecular 
surveillance to transform how our nation detects and responds 
to HIV. A key example is CDC’s Advanced Molecular Detection 
(AMD) Initiative, which supports the use of genetic science to 
help identify and characterize emerging HIV outbreaks and 
develop targeted prevention measures. 
When a person is diagnosed with HIV, they receive testing for 
drug resistance as a standard part of their medical care. That 
testing generates information about the genetic code of HIV, 
which is collected by state and local health departments and 
reported to CDC as molecular HIV surveillance data. With the 
support of the AMD Initiative, CDC scientists use advanced 
computing techniques to process and analyze massive amounts 
of this genetic data and identify hidden connections or trends. 
On a national level, the AMD Initiative is helping DHAP monitor 
for early warning signs of bursts in HIV transmission and to 
identify trends in resistance to anti-HIV drugs. At the state and 
local levels, it can be used to define groups of people who are in 
greatest need of prevention interventions and linkage to care, 
as well as communities experiencing rapid HIV transmission 
that should be targeted with testing and prevention efforts. 
Molecular surveillance can also help public health experts 
predict how fast a specific HIV transmission cluster might grow 
and how large it could become, making it easier to know whether 
HIV prevention efforts are effectively slowing an outbreak. 
In 2015, the AMD Initiative demonstrated its value when CDC 
was called upon to assist the Indiana State Department of 
Health to investigate an HIV outbreak linked to injection drug 
use in rural Scott County. From November 2014 to November 
2015, 181 people were found to have been infected with HIV, 
and over 90 percent of them were also infected with hepatitis C 
virus (HCV). To control the outbreak, DHAP scientists used the
time-tested methods of comparing laboratory and demographic 
data to find connections between infected people. 
Scanning electron 
micrograph of HIV 
particles infecting 
a human T cell. 
Advanced molecular 
detection (AMD) technology 
helped investigators trace 
connections between cases 
of HIV infection in a rural 
Indiana outbreak. 
For the first time, DHAP scientists also used molecular 
surveillance to rapidly analyze viral genetic HIV sequences from 
each case to see how fast the outbreak happened and whether it 
was spreading. They found that nearly all recent cases in the area 
had a highly similar genetic fingerprint, indicating that the virus 
had been transmitted relatively quickly (within one year). By 
comparing the genetic fingerprint of the outbreak strain to other 
reported HIV cases in the surrounding region, DHAP scientists 
were also able to confirm that the outbreak had not spread 
geographically. By determining that the outbreak was limited to 
Scott County, DHAP’s analysis enabled public health workers to 
focus limited resources among people at greatest risk and most 
in need of HIV testing, linkage to care, and PrEP. 
Indiana’s outbreak is just one example of the power of molecular 
surveillance to strengthen HIV prevention efforts in partnership 
with health departments nationwide. The approach helped 
CDC and its Indiana state partners to better understand the 
drivers of the outbreak and quickly rule out the possibility that 
it had spread to other areas of the region. DHAP and its health 
department partners will continue to apply AMD methods for 
HIV prevention, using them to help identify early warning signs 
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Comprehensive information on the U.S.





Act Against AIDS 
www.cdc.gov/actagainstaids 
CDC’s communications campaign to combat
complacency about HIV and AIDS in the United
States. Recently updated through the December
2015 launch of the “Doing It” campaign, to
encourage more Americans to get tested for HIV. 
Effective HIV Prevention Interventions 
https://effectiveinterventions.cdc.gov 
CDC information on accessible, evidence-based
programs to promote healthy behaviors among
those at risk for transmitting or acquiring HIV,
including best practices and online courses. 
Gay and Bisexual Men’s Health 
www.cdc.gov/msmhealth 
A CDC resource for men who have sex with men,
with information on how gay and bisexual men
can protect their health through all stages of life. 
National Prevention Information Network 
https://npin.cdc.gov 
The U.S. reference and referral service for
information on HIV/AIDS, viral hepatitis, sexually
transmitted diseases, and tuberculosis. NPIN
collects and disseminates data and materials to
support the work of HIV/AIDS, viral hepatitis,
STD, and TB prevention organizations and
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